Military network RallyPoint launches #FlowerOnEveryGrave

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
62
Military network RallyPoint launches #FlowerOnEveryGrave campaign to honor fallen on Memorial Day

WATERTOWN, Mass., April 11, 2017 (GLOBE NEWSWIRE) -- RallyPoint , America’s leading online network for service members and veterans, today announced the launch of the #FlowerOnEveryGrave campaign for Memorial Day 2017.

This national effort is focused on encouraging service members, veterans and civilians alike to visit their local cemetery on Memorial Day, and place at least one rose on a fallen service member’s grave.

Americans can visit remember.rallypoint.com/flowers to sign up to volunteer or donate. After indicating the state in which they live, they will be provided with information to get involved in laying roses on service members’ graves at their local cemeteries on Memorial Day.

“Memorial Day is about remembering those who’ve paid the ultimate price. We can think of no better way to celebrate the holiday than to bring together service members, veterans, veteran service organizations, great companies and supportive Americans to honor the sacrifices of America’s fallen service members by laying a rose on a grave,” said Dave Gowel, RallyPoint CEO and an Army veteran of Operation Iraqi Freedom.

RallyPoint will work with its network of 1.1 million service members and veterans to help coordinate volunteer efforts across the country, starting with Arlington National Cemetery in Virginia.

Those unable to visit a cemetery on Memorial Day can donate to help the cornerstone effort of the #FlowerOnEveryGrave initiative. RallyPoint has teamed up with non-profit The Memorial Day Flowers Foundation to lay a rose on every one of the 300,000 graves at Arlington National Cemetery in Virginia for the first time ever. Supporters can make donations as small as $5 to help fund this effort.

While RallyPoint brings broad reach and scale that carries this message over digital airwaves, the small, dedicated team at The Memorial Day Flowers Foundation has been leading the charge on the ground since 2011. Last year the Foundation coordinated 500 volunteers who handed out and placed 140,000 roses and other flowers on headstones at Arlington National Cemetery.

“We’re excited to partner with RallyPoint to lay a rose on every single grave at Arlington National Cemetery for Memorial Day,” said Johan Sohn, director of The Memorial Day Flowers Foundation. “Our team has done an incredible job of raising funds and awareness for this great cause over the past few years, and RallyPoint’s new #FlowerOnEveryGrave campaign will help scale this effort and attract more national attention.”

Supporters are encouraged to use the hashtag #FlowerOnEveryGrave on social media to help raise awareness about the campaign, and to share their own stories of honoring the fallen.

Organizations looking to become involved in the #FlowerOnEveryGrave campaign as sponsors or marketing partners can contact Kanika Misra at Kanika@RallyPoint.com . 

ABOUT RALLYPOINT: RallyPoint is the online platform where the troops talk. With more than 1.1 million members, RallyPoint is the premier social network for military service members and veterans to come together and discuss military life through both professional and personal perspectives. Visit www.RallyPoint.com to learn more. Follow RallyPoint on Facebook and Twitter @RallyPoint .

MEDIA CONTACT: Allison Borthwick (540) 208-2950 aborthwick@scoutcommsusa.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading